NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Prices $20M Public Offering
EnteroMedics (NASDAQ:ETRM), a developer of minimally invasive medical devices for the treatment of obesity, metabolic diseases and other gastrointestinal disorders, this morning priced its underwritten public offering of 20,000 units at a price to the public of $1,000 per unit. The gross proceeds to EnteroMedics is expected to be $20 million. A total of 20,000 shares of preferred stock convertible into 8.7 million shares of common stock, and warrants to purchase 8.7 million shares of common stock will be issued in the offering. The closing of the offering is expected to take place on or about August 16, 2017. To…